Revising the World Health Organization (WHO) Blue Book—‘Histological Typing of Tumours of the Central Nervous System’ Peter C. Burger OriginalPaper Pages: 3 - 7
Proliferation markers in gliomas: A comparison of BUDR, KI-67, and MIB-1 Richard L. DavisKiyoshi OndaTakao Hoshino OriginalPaper Pages: 9 - 12
Central neuronal tumors in childhood: relationship to dysplasia L. E. Becker OriginalPaper Pages: 13 - 19
Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood Lucy Balian RorkeRoger PackerJaclyn Biegel OriginalPaper Pages: 21 - 28
Primary central nervous system lymphomas—New pathological developments Kurt A. JellingerW. Paulus OriginalPaper Pages: 33 - 36
Prognostic implications of chromosome 17p deletions in human medulloblastomas Surinder K. BatraRoger E. McLendonSandra H. Bigner OriginalPaper Pages: 39 - 45
Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas Burt G. FeuersteinGayatry Mohapatra OriginalPaper Pages: 47 - 55
The neuroepithelial stem cell concept: Implications for neuro-oncology Oliver BrüstleRonald D. G. McKay OriginalPaper Pages: 57 - 59
Lineage, migration, and fate determination of postnatal subventricular zone cells in the mammalian CNS James E. Goldman OriginalPaper Pages: 61 - 64
Ganglioside modulation of the PDGF receptor Allan J. YatesHany E. SaqrJames Van Brocklyn OriginalPaper Pages: 65 - 73
Degradation of collagen type IV by C6 astrocytoma cells Rolando F. Del MaestroIndrasen S. VaithilingamWarren McDonald OriginalPaper Pages: 75 - 81
Computer-assisted analysis of the microvasculature in untreated glioblastomas Pieter WesselingJeroen AWM van der LaakPeter C Burger OriginalPaper Pages: 83 - 85
Interactions of glioma cells and extracellular matrix Werner PaulusJörg C. Tonn OriginalPaper Pages: 87 - 91
External beam radiotherapy: Hard facts and painful realities Nicholas A. VickNina A. Paleologos OriginalPaper Pages: 93 - 95
New therapies of primary CNS lymphomas and oligodendrogliomas David R. Macdonald OriginalPaper Pages: 97 - 101
Cyclosphosphamide therapy of medulloblastoma: From the laboratory to the clinic and back again (and again and again) Henry S. FriedmanSandra H. BignerDarell D. Bigner OriginalPaper Pages: 103 - 108
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab′)2-a preliminary report Darell D. BignerMark BrownMichael R. Zalutsky OriginalPaper Pages: 109 - 122